IVERIC bio Revenue and Competitors
Estimated Revenue & Valuation
- IVERIC bio's estimated annual revenue is currently $19.1M per year.
- IVERIC bio's estimated revenue per employee is $58,303
- IVERIC bio's total funding is $35M.
- IVERIC bio's current valuation is $1.6B. (January 2022)
Employee Data
- IVERIC bio has 327 Employees.
- IVERIC bio grew their employee count by 23% last year.
IVERIC bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO, Member the Board Directors | Reveal Email/Phone |
2 | VP Clinical Operations | Reveal Email/Phone |
3 | VP, Chief Staff | Reveal Email/Phone |
4 | SVP, Chief Regulatory and Product Strategy Officer | Reveal Email/Phone |
5 | VP Market Development and Reimbursement | Reveal Email/Phone |
6 | SVP and Head Quality | Reveal Email/Phone |
7 | Head Strategic Insights & Commercial Operations | Reveal Email/Phone |
8 | VP, Product Strategy & Innovation | Reveal Email/Phone |
9 | VP, Head Biometrics | Reveal Email/Phone |
10 | VP CMC | Reveal Email/Phone |
IVERIC bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is IVERIC bio?
IVERIC bio is a gene therapy focused company developing innovative treatments for patients with orphan inherited retinal diseases with significant unmet medical needs. We have a diversified and scientifically compelling pipeline of product candidates. At IVERIC bio we understand the critical importance of vision in the quality of life of patients.
keywords:N/A
$35M
Total Funding
327
Number of Employees
$19.1M
Revenue (est)
23%
Employee Growth %
$1.6B
Valuation
N/A
Accelerator
IVERIC bio News
IVERIC bio, Inc. (NASDAQ:ISEE Get Rating) has received a consensus recommendation of Buy from the eight research firms that are...
IVERIC bio also reported earnings of ($0.29) per share during the same quarter last year. The business is scheduled to issue its next earnings...
IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $91.4M | 327 | 11% | $963.1M |
#2 | $102.2M | 327 | -8% | N/A |
#3 | $59.3M | 327 | 6% | N/A |
#4 | $99.3M | 327 | 1% | N/A |
#5 | $65.4M | 327 | 7% | N/A |